Suprabha Bhat
Neurology · Houston, TXNPI 1972501047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations.
Across 228 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$593
- SK Life Science, Inc.$446
- Novartis$382
- Genentech USA, Inc.$253
- UCB, Inc.$221
- AbbVie$211
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,01097%
- Education$1233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 48 | $593 |
| SK Life Science, Inc. | 24 | $446 |
| Novartis | 23 | $382 |
| Genentech USA, Inc. | 15 | $253 |
| UCB, Inc. | 8 | $221 |
| AbbVie(2 entities) | 12 | $211 |
| Sumitomo Pharma America, Inc. | 12 | $200 |
| Neurocrine Biosciences, Inc. | 9 | $172 |
| Biogen | 8 | $148 |
| EMD Serono, Inc. | 6 | $137 |
| Acadia Pharmaceuticals Inc | 7 | $134 |
| Eisai Inc. | 8 | $132 |
| Supernus Pharmaceuticals, Inc. | 6 | $119 |
| Abbott | 3 | $118 |
| Lilly USA, LLC | 6 | $117 |
| Sanofi | 5 | $116 |
| Genentech, Inc. | 2 | $96 |
| Teva Pharmaceuticals USA, Inc. | 4 | $92 |
| Mallinckrodt Hospital Products Inc. | 4 | $78 |
| Medtronic | 1 | $69 |
| Amneal Pharmaceuticals LLC | 3 | $45 |
| Kyowa Kirin, Inc. | 2 | $45 |
| GE HealthCare | 2 | $38 |
| Livanova USA, Inc. | 2 | $35 |
| GRT US Holding, Inc. | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Neurelis, Inc. | 1 | $17 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$4,134 in reported general payments places this provider in the 55th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $215 |
Paid to pharmacies, not to this prescriber.
Other neurology in Houston
- William OndoHouston$1.4M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Randolph EvansHouston$493K
- Leorah FreemanHouston$401K
- Mazen DimachkieHouston$388K
- Zsila SadighiHouston$361K
- Joseph JankovicHouston$323K
- Raja MehannaHouston$300K
- Eddie PattonHouston$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.